UBS AM’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.5M | Buy |
|
|||||
|
2025
Q1 | $5.82M | Buy |
|
|||||
|
2024
Q4 | $5.4M | Buy |
|
|||||
|
2024
Q3 | $3.99M | Sell |
|
|||||
|
2024
Q2 | $3.86M | Buy |
|
|||||
|
2024
Q1 | $1.15M | Hold |
|
|||||
|
2023
Q4 | $1.12M | Hold |
|
|||||
|
2023
Q3 | $943K | Sell |
|
|||||
|
2023
Q2 | $1.37M | Hold |
|
|||||
|
2023
Q1 | $1.37M | Buy |
|
|||||
|
2022
Q4 | $1.18M | Sell |
|
|||||
|
2022
Q3 | $1.52M | Hold |
|
|||||
|
2022
Q2 | $1.57M | Sell |
|
|||||
|
2022
Q1 | $2.45M | Buy |
|
|||||
|
2021
Q4 | $3.17M | Sell |
|
|||||
|
2021
Q3 | $2.99M | Sell |
|
|||||
|
2021
Q2 | $2.89M | Buy |
|
|||||
|
2021
Q1 | $2.74M | Buy |
|
|||||
|
2020
Q4 | $1.73M | Sell |
|
|||||
|
2020
Q3 | $8.39M | Buy |
|
|||||
|
2020
Q2 | $2.1M | Buy |
|
|||||
|
2020
Q1 | $1.36M | Sell |
|
|||||
|
2019
Q4 | $7.39M | Sell |
|
|||||
|
2019
Q3 | $7.4M | Buy |
|
|||||
|
2019
Q2 | $8.44M | Sell |
|
|||||
|
2019
Q1 | $9.44M | Buy |
|
|||||
|
2018
Q4 | $9.99M | Sell |
|
|||||
|
2018
Q3 | $21.4M | Sell |
|
|||||
|
2018
Q2 | $21.8M | Sell |
|
|||||
|
2018
Q1 | $18.6M | Sell |
|
|||||
|
2017
Q4 | $15.7M | Buy |
|
|||||
|
2017
Q3 | $15.6M | Sell |
|
|||||
|
2017
Q2 | $14M | Sell |
|
|||||
|
2017
Q1 | $13.1M | Sell |
|
|||||
|
2016
Q4 | $13.1M | Sell |
|
|||||
|
2016
Q3 | $14M | Sell |
|
|||||
|
2016
Q2 | $16.7M | Buy |
|
|||||
|
2016
Q1 | $10.3M | Sell |
|
|||||
|
2015
Q4 | $11.1M | Sell |
|
|||||
|
2015
Q3 | $9.05M | Buy |
|
|||||
|
2015
Q2 | $9.12M | Buy |
|
|||||
|
2015
Q1 | $1.07M | Buy |
|
|||||
|
2014
Q4 | $729K | Buy |
|
|||||
|
2014
Q3 | $610K | Buy |
|
|||||
|
2014
Q2 | $712K | Sell |
|
|||||
|
2014
Q1 | $1.04M | Sell |
|
|||||
|
2013
Q4 | $849K | Sell |
|
|||||
|
2013
Q3 | $6.01M | Sell |
|
|||||
|
2013
Q2 | $42.9M | Buy |
|